Q4 2025 Earnings Call February 12, 2026 4:30 AM ESTCompany ParticipantsTadeu Marroco - CEO, Member of Management ...
Thank you, operator, and thank you all for joining PolyPid's Fourth Quarter and Full Year 2025 Earnings Conference Call.
Ascendis Pharma A/S reports €684 million revenue and positive 4Q profit; Yorvipath and TransCon CNP drive growth. See why ASND stock is a buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results